• Drug disposition and detoxification emerged as a central research axis, with studies detailing absorption, systemic distribution, metabolism, and detoxication of sulfonamides and related compounds; acetate-modulated detoxication and metabolic pathways were repeatedly explored to understand efficacy and safety [11], [15], [12], [5], [7].

• Clinical pharmacology of anticonvulsants tracked efficacy, limited sedative effects, and notable toxicity, guiding dosing and safety for dilantin and related agents through case reports and cohort studies [6], [4], [1].

• Antibiotic chemotherapy and sulfonamide pharmacology emphasize altering gut flora and antimicrobial action, with succinylsulfathiazole and sulfonamides evaluated for therapeutic use and resistance-relevant relationships to methionine and purine antagonists [8], [9], [13], [11].

• Clinical pharmacology methods and routes of administration illustrate how intravenous, rectal, ocular, and other delivery modes influence onset, duration, and safety, informing regimens for digoxin, aminophylline, atropine-based mydriatics, and mercurial diuretics [17], [18], [10], [20], [19].